1-p-tolyl-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA1275633

Cas Number: 343372-45-2

PubChem CID: 3310540

Max Phase: Preclinical

Molecular Formula: C17H11F3N4

Molecular Weight: 328.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2nnc3c(C(F)(F)F)nc4ccccc4n23)cc1

Standard InChI:  InChI=1S/C17H11F3N4/c1-10-6-8-11(9-7-10)15-22-23-16-14(17(18,19)20)21-12-4-2-3-5-13(12)24(15)16/h2-9H,1H3

Standard InChI Key:  PDEQZKMFUXKNAX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -5.1056   -3.9541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1068   -4.7815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3919   -5.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3937   -3.5414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6784   -3.9505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6776   -4.7773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2520   -3.9436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9679   -3.5363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2473   -4.7735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9639   -5.1849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7942   -5.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9725   -6.0821    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6346   -5.3281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3478   -6.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1532   -6.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7066   -7.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4538   -7.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6426   -7.9959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0927   -7.3836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5401   -3.5267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8231   -3.9349    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5451   -2.7017    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9603   -2.9398    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0066   -8.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  6 10  1  0
 11 14  1  0
  3  6  2  0
 14 15  2  0
  9  7  1  0
 15 16  1  0
  1  2  2  0
 16 17  2  0
  7  8  2  0
 17 18  1  0
  8  5  1  0
 18 19  2  0
 19 14  1  0
  9 10  1  0
  7 20  1  0
  5  4  2  0
 20 21  1  0
  4  1  1  0
 20 22  1  0
 20 23  1  0
  2  3  1  0
 17 24  1  0
M  END

Associated Targets(Human)

2008 (263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4E Tchem Lysine-specific demethylase 4D-like (40243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALDH1A1 Tchem Aldehyde dehydrogenase 1A1 (77053 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HPGD Tchem 15-hydroxyprostaglandin dehydrogenase [NAD+] (24926 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFE2L2 Tchem Nuclear factor erythroid 2-related factor 2 (95332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMAD3 Tchem Mothers against decapentaplegic homolog 3 (68039 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRCA1 Tchem Breast cancer type 1 susceptibility protein (15908 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MBNL1 Tbio Muscleblind-like protein 1 (34431 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2-CD81 (19978 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
clpP ATP-dependent Clp protease proteolytic subunit (20705 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 328.30Molecular Weight (Monoisotopic): 328.0936AlogP: 4.27#Rotatable Bonds: 1
Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.94CX LogP: 3.79CX LogD: 3.79
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.52Np Likeness Score: -1.64

References

1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G..  (2010)  Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors.,  18  (22): [PMID:20951595] [10.1016/j.bmc.2010.09.065]
2. PubChem BioAssay data set, 
3. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA..  (2018)  Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.,  362  (6419): [PMID:30523084] [10.1126/science.aat9446]